New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease.
Health tech startups warn that overregulating AI could hamper innovation
Entrepreneurs across the country desperate to bring the power of AI into health care are urging Washington to consider the risk of blocking innovation, bringing